EDP Sciences logo
Submit your paper
Search
Menu
Home All issues Volume 21 / No 3 (May-June 2014) OCL, 21 3 (2014) D308 References
Open Access
Issue
OCL
Volume 21, Number 3, May-June 2014
Article Number D308
Number of page(s) 6
Section Dossier: Vitamin D, vitamin or hormone? / La vitamine D, vitamine ou hormone ?
DOI https://doi.org/10.1051/ocl/2013055
Published online 29 April 2014
  • Anderson JL, May HT, Horne BD, et al. 2010. Intermountain Heart Collaborative (IHC) Study Group. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am. J. Cardiol. 106: 963–968. [CrossRef] [PubMed] [Google Scholar]
  • Autier P, Gandini S. 2007. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch. Intern. Med. 167: 1730–1707 [Google Scholar]
  • Avenell A, Gillespie WJ, Gillespie LD, O’Connell D. 2009. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst. Rev. 15: CD000227. [Google Scholar]
  • Bjelakovic G, Gluud LL, Nikolova D, et al. 2011. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst. Rev. 6: CD007470. [Google Scholar]
  • Bland R, Markovic D, Hills CE, et al. 2004. Expression of 25-hydroxyvitamin D3–1alpha-hydroxylase in pancreatic islets. J. Steroid. Biochem. Mol. Biol. 89-90: 121–125. [CrossRef] [PubMed] [Google Scholar]
  • Bolland MJ, Barber PA, Doughty RN, et al. 2008. Vascular events in healthy older women receiving calcium supplementation randomised controlled trial. BMJ 336: 262–266. [Google Scholar]
  • Chapuy MC, Arlot ME, Duboeuf F, et al. 1992. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N. Engl. J. Med. 327: 1637–1642. [Google Scholar]
  • Chen S, Glenn DJ, Ni W, et al. 2008. Expression of the vitamin d receptor is increased in the hypertrophic heart. Hypertension 52: 1106–1112 [Google Scholar]
  • Cormier C, Courbebaisse M, Maury E, Thervet E, Souberbielle JC. 2010. Effect of vitamin D deficiency on cardiovascular risk. J. Mal. Vasc. 35: 235–241. [CrossRef] [PubMed] [Google Scholar]
  • Davidson MB, Duran P, Lee ML, Friedman TC. 2013. High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D. Diabetes Care 36: 260–266. [CrossRef] [PubMed] [Google Scholar]
  • Doorenbos CR, van den Born J, Navis G, de Borst MH. 2009. Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism. Nat. Rev. Nephrol. 5: 691–700 [CrossRef] [PubMed] [Google Scholar]
  • Draznin B, Sussman K, Kao M, Lewis D, Sherman N. 1987. The existence of an optimal range of cytosolic free calcium for insulin-stimulated glucose transport in rat adipocytes. J. Biol. Chem. 262: 14385–14388. [PubMed] [Google Scholar]
  • Dror Y, Giveon SM, Hoshen M, Feldhamer I, Balicer RD, Feldman BS. Vitamin D levels for preventing acute coronary syndrome and mortality: evidence of a nonlinear association. J. Clin. Endocrinol. Metab. 98: 2160–2167 [Google Scholar]
  • Dunlop TW, Väisänen S, Frank C, Molnár F, Sinkkonen L, Carlberg C. 2005. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1α,25-dihydroxyvitamin D3 and its nuclear receptor. J. Mol. Biol. 349: 248–260. [CrossRef] [PubMed] [Google Scholar]
  • Durup D, Jorgensen HL, Christensen J, Schwarz P, Heegaard AM, Lind B. 2012. A reverse J-shaped association of all cause mortality with serum 25-hydroxyvitaminD in general practice: the CopD Study. J. Clin. Endocrinol. Metab. 97: 2644–2652 [CrossRef] [PubMed] [Google Scholar]
  • Elamin MB, Abu Elnour NO, Elamin KB, et al. 2011. Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 96: 1931–1942 [CrossRef] [PubMed] [Google Scholar]
  • George PS, Pearson ER, Witham MD. 2012. Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabet Med. 29: 142–150. [CrossRef] [Google Scholar]
  • Holick M, Binkley N, Bischoff-Ferrari H, et al. 2011. Endocrine Society. Evaluation, treatment and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96: 1911–1930. [Google Scholar]
  • Hypponen E, Power C. 2006. Vitamin D status and glucose homeostasis in the 1958 British birth cohort: The role of obesity. Diabetes Care 29: 2244–2246. [CrossRef] [PubMed] [Google Scholar]
  • Johnson JA, Grande JP, Roche PC, Kumar R. 1994. Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28k in human and rat pancreas. Am. J. Physiol. 267: E356–360. [PubMed] [Google Scholar]
  • Karakas M, Thorand B, Zierer A, et al. 2013. Low levels of serum 25-hydroxyvitamin D are associated with increased risk of myocardial infarction, especially in women: results from the MONICA/KORA Augsburg case-cohort study. J. Clin. Endocrinol. Metab. 98: 272–280. [CrossRef] [PubMed] [Google Scholar]
  • Kestenbaum B, Katz R, de Boer I, et al. 2011. Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J. Am. Coll. Cardiol. 58: 1433–1441. [CrossRef] [PubMed] [Google Scholar]
  • Krause R, Buhring M, Hopfenmuller W, Holick M, Sharma AM. 1998. Ultraviolet B and blood pressure. Lancet 352: 709–710. [CrossRef] [Google Scholar]
  • Kunutsor SK, Apekey TA, Steur M. 2013. Vitamin D and risk of future hypertension: meta-analysis of 283 537 participants. Eur. J. Epidemiol. DOI: 10.1007/s10654-013-9874. [Google Scholar]
  • Larsen T, Mose FH, Bech JN, Hansen A.B, Pedersen EB. 2012. Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized, placebo-controlled trial. Am. J. Hypertens. 25: 1215–1222. [CrossRef] [PubMed] [Google Scholar]
  • Lee P, Greenfield JR, Campbell LV. 2009. Vitamin D insufficiency–a novel mechanism of statin-induced myalgia? Clin. Endocrinol. 71: 154–155. [CrossRef] [Google Scholar]
  • London G, Guerin A, Verbeke F, et al. 2007. Mineral metabolism and arterial functions in end-stage renal disease:potential role of 25-hydroxyvitamin D deficiency. J. Am. Soc. Nephrol. 18: 613–662. [CrossRef] [PubMed] [Google Scholar]
  • Maestro B, Dávila N, Carranza MC, Calle C. 2003. Identification of a Vitamin D response element in the human insulin receptor gene promoter. J. Steroid. Biochem. Mol. Biol. 84: 223–230. [CrossRef] [PubMed] [Google Scholar]
  • Maestro B, Molero S, Bajo S, Dávila N, Calle C. 2002. Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D(3). Cell Biochem. Funct. 20: 227–232. [CrossRef] [PubMed] [Google Scholar]
  • Maestro B, Campión J, Dávila N, Calle C. 2000. Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr. J. 47: 383–391. [CrossRef] [PubMed] [Google Scholar]
  • Manson JE, Bassuk SS, Lee JM, et al. 2012. The vitamin D and Omega A-3 Trial (Vital) nationale and design of a charge randomized controlled trial of vitamin D and marine omega 3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp. Clin. Trials 33 : 159–171 [CrossRef] [PubMed] [Google Scholar]
  • Mitri J, Dawson-Hughes B, Hu FB, Pittas AG. 2011. Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am. J. Clin. Nutr. 94: 486–494. [Google Scholar]
  • Pfeifer M, Begerow B, Minne H, Nachtigall D, Hansen C. 2001. Effects of a short-term vitamin D3 and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J. Clin. Endocrinol. Metab. 86: 1633–1637 [PubMed] [Google Scholar]
  • Pilz S, Tomaschitz A, März W, Drechsler C, Ritz E, Zittermann A. 2011. Vitamin D, cardiovascular disease and mortality. Clin. Endocrinol. 75: 575–584. [CrossRef] [Google Scholar]
  • Pilz S, Iodice S, Zittermann A, Grant WB, Gandini S. 2011. Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am. J. Kidney Dis. 58: 374–382. [Google Scholar]
  • Pilz S, Tomaschitz A, Drechsler C, Dekker JM, März W. Vitamin D deficiency and myocardial diseases. Mol. Nutr. Food Res. 54: 1103–1113. [PubMed] [Google Scholar]
  • Pittas AG, Lau J, Hu FB, Dawson-Hughes B. 2007. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 92: 2017–2029. [CrossRef] [PubMed] [Google Scholar]
  • Pittas AG, Dawson-Hughes B, Li T, et al. 2006. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29: 650–656. [CrossRef] [PubMed] [Google Scholar]
  • Pittas AG, Chung M, Trikalinos T, et al. 2000. Systematic review: vitaminD and cardiometabolic outcomes. An. Intern. Med. 152: 307–314 [CrossRef] [Google Scholar]
  • Souberbielle JC, Courbebaisse M, Cormier C, et al. 2012. When should we measure vitamin D concentration in clinical practice? Scand J. Clin. Lab. Invest. 243: 129–135. [PubMed] [Google Scholar]
  • Tarcin O, Yavuz DG, Ozben B, et al. 2009. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J. Clin. Endocrinol. Metab. 4023–4030. [Google Scholar]
  • Trummer O, Pilz S, Hoffmann MM, et al. 2013. Vitamin D and Mortality: A Mendelian Randomization Study. Clin. Chem. 59: 793–797. [CrossRef] [PubMed] [Google Scholar]
  • Wang L, Song Y, Manson JE, et al. 2012. Circulating 25-hydroxy-vitamin d and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ. Cardiovasc. Qual. Outcomes. 5: 819–829. [CrossRef] [PubMed] [Google Scholar]
  • Wang L, Manson JE, Song Y, Sesso HD. 2010. Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann. Intern. Med. 152: 315–323 [CrossRef] [PubMed] [Google Scholar]
  • Witham MD, Nadir MA, Struthers AD. 2009. Effect of vitamin D on blood pressure’ a systematic review and meta-analysis. J. hypertens. 27: 1948–1954. [Google Scholar]
  • Zeitz U, Weber K, Soegiarto DW, Wolf E, Balling R, Erben RG. 2003. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J. 17: 509–511. [PubMed] [Google Scholar]
  • Zittermann A, Kuhn J, Dreier J, Knabbe C, Gummert JF, Borgermann J. 2013. Vitamin D status and the risk of major adverse cardiac and cerebrovascular events in cardiac surgery. Eur. Heart J. 34: 1358–1364 [CrossRef] [PubMed] [Google Scholar]
  • Zitterman A, Iodice S, Pilz S, Grant WB, Bagnardi V, Gandini S, 2012. Vitamin D deficiency and mortality risk in general population: a meta analysis of prospective cohort studies. Am. J. Clin. Nutr. 95: 91–100. [Google Scholar]
  • Zittermann A, Schleithoff S, Koerfer R. 2007. Vitamin D and vascular calcification. Curr. Opin. Lipidol. 18: 41–46. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.